A qualitative study to explore the symptoms and impacts of Crohn’s disease and to develop the Crohn’s Disease Diary
2022 · Quality of Life Research · 14 citations
https://doi.org/10.1007/s11136-022-03233-9
T
Tom Keeley
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
5
Papers
30
Citations
3
h-index
2
i10-index
Tom Keeley is an academic researcher from GlaxoSmithKline (United Kingdom). The author has contributed to research in topics: Schizophrenia research and treatment & SARS-CoV-2 and COVID-19 Research & Inflammatory Bowel Disease. The author has an h-index of 3, co-authored 5 publications.
ORCID: 0000-0003-1584-9093Papers by this author
worksContent validity and psychometric properties of the inFLUenza Patient-Reported Outcome Plus (FLU-PRO Plus©) instrument in patients with COVID-19
2023 · Quality of Life Research · 11 citations
https://doi.org/10.1007/s11136-022-03336-3
Chronic rhinosinusitis with nasal polyps (CRSwNP) symptom verbal response scales: content validity testing for use in adults with CRSwNP
2024 · Journal of Patient-Reported Outcomes · 1 citations
https://doi.org/10.1186/s41687-024-00827-4
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat